Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. SFOSF

Full chart Compare
Set alert

Price alert · SFOSF

All alert types
2.18 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

Day range unavailable

1.93 52-week range 3.30
YTD
-13.00%
1 year
-34.09%

Financial health

Altman Z-Score

1.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 3
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 1

Valuation

P/E 13.9×
FY 2016: 18.2×FY 2017: 33.2×FY 2018: 18.4×FY 2019: 15.7×FY 2020: 21.3×FY 2021: 15.0×FY 2022: 15.5×FY 2023: 17.5×FY 2024: 12.6×FY 2025: 13.9×
FY 2016 5y median 15.0× FY 2025
P/S 1.1×
FY 2016: 3.5×FY 2017: 5.6×FY 2018: 2.0×FY 2019: 1.8×FY 2020: 2.6×FY 2021: 1.8×FY 2022: 1.3×FY 2023: 1.0×FY 2024: 0.9×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
P/B 0.9×
FY 2016: 2.3×FY 2017: 4.1×FY 2018: 1.8×FY 2019: 1.6×FY 2020: 2.1×FY 2021: 1.8×FY 2022: 1.3×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF 60.5×
FY 2016: 272×FY 2017: 254×FY 2018: -221×FY 2019: -70.9×FY 2020: -42.0×FY 2021: -69.6×FY 2022: -34.5×FY 2023: -21.7×FY 2024: 524×FY 2025: 60.5×
FY 2016 5y median -21.7× FY 2025
EV/EBITDA 11.5×
FY 2016: 11.8×FY 2017: 21.0×FY 2018: 11.1×FY 2019: 9.2×FY 2020: 12.7×FY 2021: 9.7×FY 2022: 9.1×FY 2023: 10.5×FY 2024: 6.2×FY 2025: 11.5×
FY 2016 5y median 9.7× FY 2025
EV/Sales 1.7×
FY 2016: 3.9×FY 2017: 6.3×FY 2018: 2.6×FY 2019: 2.3×FY 2020: 3.0×FY 2021: 2.2×FY 2022: 1.6×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.7×
FY 2016 5y median 1.6× FY 2025
FCF Yield 1.7%
FY 2016: 0.4%FY 2017: 0.4%FY 2018: -0.5%FY 2019: -1.4%FY 2020: -2.4%FY 2021: -1.4%FY 2022: -2.9%FY 2023: -4.6%FY 2024: 0.2%FY 2025: 1.7%
FY 2016 5y median -1.4% FY 2025

Profitability

Gross Margin 49.9%
FY 2016: 54.1%FY 2017: 58.9%FY 2018: 58.4%FY 2019: 59.6%FY 2020: 55.7%FY 2021: 48.1%FY 2022: 47.3%FY 2023: 47.8%FY 2024: 48.0%FY 2025: 49.9%
FY 2016 5y median 48.0% FY 2025
Operating Margin 6.3%
FY 2016: 23.2%FY 2017: 22.0%FY 2018: 14.2%FY 2019: 22.4%FY 2020: 15.6%FY 2021: 16.2%FY 2022: 18.9%FY 2023: 8.0%FY 2024: 10.3%FY 2025: 6.3%
FY 2016 5y median 10.3% FY 2025
Net Margin 8.1%
FY 2016: 19.2%FY 2017: 16.9%FY 2018: 10.9%FY 2019: 11.6%FY 2020: 12.1%FY 2021: 12.1%FY 2022: 8.5%FY 2023: 5.8%FY 2024: 6.7%FY 2025: 8.1%
FY 2016 5y median 8.1% FY 2025
ROE 6.7%
FY 2016: 12.6%FY 2017: 12.3%FY 2018: 9.7%FY 2019: 10.4%FY 2020: 9.9%FY 2021: 12.1%FY 2022: 8.4%FY 2023: 5.2%FY 2024: 5.9%FY 2025: 6.7%
FY 2016 5y median 6.7% FY 2025
ROIC 2.0%
FY 2016: 8.2%FY 2017: 6.4%FY 2018: 5.1%FY 2019: 7.8%FY 2020: 6.0%FY 2021: 6.6%FY 2022: 8.3%FY 2023: 3.1%FY 2024: 3.6%FY 2025: 2.0%
FY 2016 5y median 3.6% FY 2025
ROA 2.7%
FY 2016: 6.4%FY 2017: 5.0%FY 2018: 3.8%FY 2019: 4.4%FY 2020: 4.4%FY 2021: 5.1%FY 2022: 3.5%FY 2023: 2.1%FY 2024: 2.4%FY 2025: 2.7%
FY 2016 5y median 2.7% FY 2025

Growth (YoY)

Revenue -1.6%
FY 2016: 16.0%FY 2017: 26.7%FY 2018: 34.4%FY 2019: 14.7%FY 2020: 6.0%FY 2021: 28.7%FY 2022: 12.7%FY 2023: -5.8%FY 2024: -0.8%FY 2025: -1.6%
FY 2016 FY 2025
Operating Income -40.3%
FY 2016: 3.1%FY 2017: 19.9%FY 2018: -13.2%FY 2019: 81.4%FY 2020: -26.4%FY 2021: 33.7%FY 2022: 31.4%FY 2023: -60.1%FY 2024: 28.3%FY 2025: -40.3%
FY 2016 FY 2025
EPS (diluted) 21.2%
FY 2016: 13.2%FY 2017: 5.8%FY 2018: -15.7%FY 2019: 21.5%FY 2020: 10.0%FY 2021: 29.4%FY 2022: -22.7%FY 2023: -37.8%FY 2024: 16.9%FY 2025: 21.2%
FY 2016 FY 2025
Free Cash Flow 1045.0%
FY 2016: -51.2%FY 2017: 117.8%FY 2018: -154.9%FY 2019: -229.0%FY 2020: -151.1%FY 2021: 44.9%FY 2022: -63.2%FY 2023: -15.0%FY 2024: 103.5%FY 2025: 1045.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.9×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 1.0×FY 2019: 1.2×FY 2020: 1.0×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 1.0×FY 2024: 0.9×FY 2025: 0.9×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.8×
FY 2016: 0.9×FY 2017: 0.7×FY 2018: 0.8×FY 2019: 0.9×FY 2020: 0.8×FY 2021: 0.9×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 0.7×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Debt / Equity 0.8×
FY 2016: 0.5×FY 2017: 0.8×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 3.9×
FY 2016: 1.1×FY 2017: 2.3×FY 2018: 2.5×FY 2019: 1.7×FY 2020: 1.9×FY 2021: 1.6×FY 2022: 1.8×FY 2023: 3.0×FY 2024: 2.1×FY 2025: 3.9×
FY 2016 5y median 2.1× FY 2025
Interest Coverage 2.1×
FY 2016: 7.0×FY 2017: 7.1×FY 2018: 3.8×FY 2019: 6.0×FY 2020: 5.4×FY 2021: 7.7×FY 2022: 8.6×FY 2023: 2.5×FY 2024: 3.0×FY 2025: 2.1×
FY 2016 5y median 3.0× FY 2025

Dividends

Dividend Yield 4.2%
FY 2016: 2.3%FY 2017: 1.4%FY 2018: 3.6%FY 2019: 1.6%FY 2020: 1.3%FY 2021: 1.5%FY 2022: 2.5%FY 2023: 5.9%FY 2024: 5.9%FY 2025: 4.2%
FY 2016 5y median 4.2% FY 2025
Payout Ratio 59.2%
FY 2016: 42.5%FY 2017: 45.9%FY 2018: 65.6%FY 2019: 24.6%FY 2020: 27.3%FY 2021: 23.3%FY 2022: 38.5%FY 2023: 102.9%FY 2024: 74.4%FY 2025: 59.2%
FY 2016 5y median 59.2% FY 2025

Annual · latest fiscal year ends 2025-12-31